Nextech Invest Ltd.
Q3 2026 13F-HR Holdings
Net value change ($000)
+125,003
(5.9%)
New positions
4
Sold out positions
1
Turnover %
4.3%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| RVMD | 136,667 | 9.6% |
| ATTOVIA THERAPEUTICS INC | 31,454 | NEW |
| ELECTRA THERAPEUTICS INC | 29,658 | NEW |
| PARABILIS MEDICINES INC | 22,943 | 18.0% |
| ORIC | 18,910 | 24.4% |
| AVTX | 11,743 | NEW |
| BRAVEHEART BIO INC | 8,417 | NEW |
| SLN | 8,049 | 77.0% |
| ENGN | 628 | 15.6% |
| ZYME | 389 | 1.3% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|